Oral oncology encompasses prevention, early recognition, diagnosis, treatment, and continuing care of oral and related head and neck malignancies. This session explores oral cancer screening, potentially malignant disorders, biomarkers, early diagnostic approaches, head and neck cancer, therapeutic advances, and technologies supporting cancer detection and management.
Abstract Scope and Participation
The session welcomes basic, translational, clinical, and epidemiological research, diagnostic studies, biomarker investigations, treatment advances, prevention strategies, survivorship research, and clinical cases. Dentists, oncologists, surgeons, pathologists, researchers, and multidisciplinary cancer-care professionals are encouraged to contribute.
Oral Potentially Malignant Disorders (OPMDs) such as Oral Submucous Fibrosis (OSMF) and Oral Leukoplakia (OL) are associated with a risk of malignant transformation into oral cancer. Interleukin-1β…
Exfoliative cytology has long been regarded as a useful screening examination in oral medicine because it is simple to perform, minimally invasive, and imposes little burden on patients. Early…
Can lack of adherence to prevention be a factor contributing to large resections of mouth tumors and forcing the creation of new techniques for reconstruction purposes?” DIRSCHNABE... SASSI, 2020…
India faces a significant burden of oral diseases, with tobacco use being a major contributor. As an expert in tobacco de-addiction, dental public health, and oral cancer, I combine clinical…
Medication-related osteonecrosis of the jaw is defined as the necrosis of jawbone cells in patients who are on drugs known to increase the risk of the disease. The condition may lead to several…
Angiosarcomas are a rare soft tissue tumour originating from the endothelial cells of lymphatic or vascular origin. They are aggressive, spread haematologically, and a typically associated with a…
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Oral and poster slots for original Oral Cancer & Oncology work, reviewed by the scientific committee.
Meet dentists, oral-health researchers, and clinical leaders from around the world across three days.
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Plenary lectures from leading voices shaping Oral Cancer & Oncology research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Oral Cancer & Oncology track is a dedicated stream within Dental 2027 covering the latest research, clinical innovation, and best practice in Oral Cancer & Oncology. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Educators, doctoral students, and dentists, oral-health researchers, and clinical leaders with an interest in Oral Cancer & Oncology are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. Dental 2027 is a hybrid conference — attend the Oral Cancer & Oncology track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
Register